Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311699624> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4311699624 abstract "<h3>Background</h3> Previous studies showed that lumacaftor-ivacaftor (LUMA-IVA) provides meaningful clinical benefits in patients with cystic fibrosis who are homozygous for the Phe508del CFTR mutation. However, little is known about the patient perspectives and overall health related quality of life (HRQoL) following lumacaftor-ivacaftor initiation. <h3>Methods</h3> Forty -four adult CF patients with homozygous for the Phe508del CFTR mutation were evaluated at baseline and prospectively three monthly for one-year post commencement of lumacaftor-ivacaftor using validated questionnaires assessing fatigue level (Functional Assessment of Chronic Illness Therapy -Fatigue (FACIT-fatigue) scale, sleep quality (Pittsburgh Sleep Quality Index (PSQI) score), sinonasal symptoms (Modified version of Sino-Nasal Outcome Test (SNOT-22), mental health (Patient Health Questionnaire -9 (PHQ-9) and General Anxiety Disorder-7 (GAD-7)) and CF-related quality of life (Cystic Fibrosis Questionnaire Revised (CFQ-R). <h3>Results</h3> We observed mean +6.8± 13.0 (p=0.001) improvement in respiratory, mean+4.7±15.7 (p=0.04) improvement in body image and mean +16.1±36.0 (p=0.003) improvement in weight domains of CFQ-R. Mean -0.61 ± 1.9 (p=0.043) reduction in global PSQI score and sustained mean -3.0± 4.3 reduction (p=0.000) in modified SNOT-22 score one year after LUMA-IVA treatment were noted. No change or worsening in anxiety and depression scores (GADS-7 and PHQ-9) were reported. <h3>Conclusion</h3> Lumacaftor-ivacaftor combination resulted in significant benefits in rhinologic QoL, sleep quality and respiratory, body image and weight domains of a disease -based tool cystic fibrosis questionnaire -revised (CFQ-R). Patient report outcome from CF patients suggest that LUMA-IVA treatment is associated with improved overall quality of life in PWCF. Multicentre, larger studies are required to further quantify the impact of LUMA-IVA on patient reported health and well being outcomes." @default.
- W4311699624 created "2022-12-28" @default.
- W4311699624 creator A5020158692 @default.
- W4311699624 creator A5036640554 @default.
- W4311699624 creator A5066830950 @default.
- W4311699624 creator A5073603226 @default.
- W4311699624 creator A5077222455 @default.
- W4311699624 creator A5077419507 @default.
- W4311699624 creator A5082286207 @default.
- W4311699624 creator A5084346216 @default.
- W4311699624 date "2022-11-01" @default.
- W4311699624 modified "2023-10-14" @default.
- W4311699624 title "P66 Patient-reported outcomes in patients with cystic fibrosis with homozygous for the Phe508del CFTR mutation on lumacaftor-ivacaftor treatment: results from an observational study" @default.
- W4311699624 doi "https://doi.org/10.1136/thorax-2022-btsabstracts.202" @default.
- W4311699624 hasPublicationYear "2022" @default.
- W4311699624 type Work @default.
- W4311699624 citedByCount "0" @default.
- W4311699624 crossrefType "proceedings-article" @default.
- W4311699624 hasAuthorship W4311699624A5020158692 @default.
- W4311699624 hasAuthorship W4311699624A5036640554 @default.
- W4311699624 hasAuthorship W4311699624A5066830950 @default.
- W4311699624 hasAuthorship W4311699624A5073603226 @default.
- W4311699624 hasAuthorship W4311699624A5077222455 @default.
- W4311699624 hasAuthorship W4311699624A5077419507 @default.
- W4311699624 hasAuthorship W4311699624A5082286207 @default.
- W4311699624 hasAuthorship W4311699624A5084346216 @default.
- W4311699624 hasConcept C118552586 @default.
- W4311699624 hasConcept C126322002 @default.
- W4311699624 hasConcept C159110408 @default.
- W4311699624 hasConcept C169900460 @default.
- W4311699624 hasConcept C1862650 @default.
- W4311699624 hasConcept C23131810 @default.
- W4311699624 hasConcept C2776245837 @default.
- W4311699624 hasConcept C2776502428 @default.
- W4311699624 hasConcept C2776938444 @default.
- W4311699624 hasConcept C2778205975 @default.
- W4311699624 hasConcept C2778428886 @default.
- W4311699624 hasConcept C2778664715 @default.
- W4311699624 hasConcept C2779951463 @default.
- W4311699624 hasConcept C2781326671 @default.
- W4311699624 hasConcept C2983189541 @default.
- W4311699624 hasConcept C558461103 @default.
- W4311699624 hasConcept C71924100 @default.
- W4311699624 hasConceptScore W4311699624C118552586 @default.
- W4311699624 hasConceptScore W4311699624C126322002 @default.
- W4311699624 hasConceptScore W4311699624C159110408 @default.
- W4311699624 hasConceptScore W4311699624C169900460 @default.
- W4311699624 hasConceptScore W4311699624C1862650 @default.
- W4311699624 hasConceptScore W4311699624C23131810 @default.
- W4311699624 hasConceptScore W4311699624C2776245837 @default.
- W4311699624 hasConceptScore W4311699624C2776502428 @default.
- W4311699624 hasConceptScore W4311699624C2776938444 @default.
- W4311699624 hasConceptScore W4311699624C2778205975 @default.
- W4311699624 hasConceptScore W4311699624C2778428886 @default.
- W4311699624 hasConceptScore W4311699624C2778664715 @default.
- W4311699624 hasConceptScore W4311699624C2779951463 @default.
- W4311699624 hasConceptScore W4311699624C2781326671 @default.
- W4311699624 hasConceptScore W4311699624C2983189541 @default.
- W4311699624 hasConceptScore W4311699624C558461103 @default.
- W4311699624 hasConceptScore W4311699624C71924100 @default.
- W4311699624 hasLocation W43116996241 @default.
- W4311699624 hasOpenAccess W4311699624 @default.
- W4311699624 hasPrimaryLocation W43116996241 @default.
- W4311699624 hasRelatedWork W1550207231 @default.
- W4311699624 hasRelatedWork W2267880852 @default.
- W4311699624 hasRelatedWork W2324828255 @default.
- W4311699624 hasRelatedWork W2463791500 @default.
- W4311699624 hasRelatedWork W2604789127 @default.
- W4311699624 hasRelatedWork W2806038027 @default.
- W4311699624 hasRelatedWork W2953869265 @default.
- W4311699624 hasRelatedWork W4308223774 @default.
- W4311699624 hasRelatedWork W4311699624 @default.
- W4311699624 hasRelatedWork W80541691 @default.
- W4311699624 isParatext "false" @default.
- W4311699624 isRetracted "false" @default.
- W4311699624 workType "article" @default.